South Korea · Delayed Price · Currency is KRW Sam-A Pharm. Statistics
Total Valuation
Sam-A Pharm. has a market cap or net worth of KRW 101.50 billion. The enterprise value is 23.09 billion.
| Market Cap | 101.50B |
| Enterprise Value | 23.09B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
Sam-A Pharm. has 6.10 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 6.10M |
| Shares Outstanding | 6.10M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 68.45% |
| Owned by Institutions (%) | n/a |
| Float | 1.93M |
Valuation Ratios
The trailing PE ratio is 6.61.
| PE Ratio | 6.61 |
| Forward PE | n/a |
| PS Ratio | 1.23 |
| PB Ratio | 0.45 |
| P/TBV Ratio | 0.46 |
| P/FCF Ratio | 7.08 |
| P/OCF Ratio | 5.59 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 1.27, with an EV/FCF ratio of 1.61.
| EV / Earnings | 1.50 |
| EV / Sales | 0.28 |
| EV / EBITDA | 1.27 |
| EV / EBIT | 1.70 |
| EV / FCF | 1.61 |
Financial Position
The company has a current ratio of 6.51, with a Debt / Equity ratio of 0.04.
| Current Ratio | 6.51 |
| Quick Ratio | 5.57 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.51 |
| Debt / FCF | 0.69 |
| Interest Coverage | 27.67 |
Financial Efficiency
Return on equity (ROE) is 7.03% and return on invested capital (ROIC) is 4.06%.
| Return on Equity (ROE) | 7.03% |
| Return on Assets (ROA) | 3.76% |
| Return on Invested Capital (ROIC) | 4.06% |
| Return on Capital Employed (ROCE) | 6.49% |
| Revenue Per Employee | 270.55M |
| Profits Per Employee | 50.31M |
| Employee Count | 305 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 1.98 |
Taxes
In the past 12 months, Sam-A Pharm. has paid 4.39 billion in taxes.
| Income Tax | 4.39B |
| Effective Tax Rate | 22.23% |
Stock Price Statistics
The stock price has decreased by -22.65% in the last 52 weeks. The beta is 0.22, so Sam-A Pharm.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -22.65% |
| 50-Day Moving Average | 16,987.80 |
| 200-Day Moving Average | 17,036.15 |
| Relative Strength Index (RSI) | 37.82 |
| Average Volume (20 Days) | 8,162 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sam-A Pharm. had revenue of KRW 82.52 billion and earned 15.34 billion in profits. Earnings per share was 2,514.13.
| Revenue | 82.52B |
| Gross Profit | 50.58B |
| Operating Income | 14.89B |
| Pretax Income | 19.73B |
| Net Income | 15.34B |
| EBITDA | 19.46B |
| EBIT | 14.89B |
| Earnings Per Share (EPS) | 2,514.13 |
Balance Sheet
The company has 88.31 billion in cash and 9.91 billion in debt, giving a net cash position of 78.41 billion or 12,846.68 per share.
| Cash & Cash Equivalents | 88.31B |
| Total Debt | 9.91B |
| Net Cash | 78.41B |
| Net Cash Per Share | 12,846.68 |
| Equity (Book Value) | 223.99B |
| Book Value Per Share | 36,699.70 |
| Working Capital | 106.02B |
Cash Flow
In the last 12 months, operating cash flow was 18.16 billion and capital expenditures -3.82 billion, giving a free cash flow of 14.34 billion.
| Operating Cash Flow | 18.16B |
| Capital Expenditures | -3.82B |
| Free Cash Flow | 14.34B |
| FCF Per Share | 2,349.24 |
Margins
Gross margin is 61.29%, with operating and profit margins of 18.04% and 18.59%.
| Gross Margin | 61.29% |
| Operating Margin | 18.04% |
| Pretax Margin | 23.91% |
| Profit Margin | 18.59% |
| EBITDA Margin | 23.58% |
| EBIT Margin | 18.04% |
| FCF Margin | 17.38% |
Dividends & Yields
This stock pays an annual dividend of 800.00, which amounts to a dividend yield of 4.81%.
| Dividend Per Share | 800.00 |
| Dividend Yield | 4.81% |
| Dividend Growth (YoY) | 6.67% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 31.82% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 4.82% |
| Earnings Yield | 15.12% |
| FCF Yield | 14.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 29, 2008. It was a forward split with a ratio of 1.02005.
| Last Split Date | Dec 29, 2008 |
| Split Type | Forward |
| Split Ratio | 1.02005 |
Scores
Sam-A Pharm. has an Altman Z-Score of 5.09 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.09 |
| Piotroski F-Score | 5 |